Answers are grounded in this paper and cite their sources.
Transcatheter arterial embolization (TAE) combined with transcatheter arterial infusion (TAI) was done in 58 patients with unresectable hepatic malignancies. The actuarial 1‐year survival rate of the patients was 56.2%. Elective hepatic resection was performed on 10 patients following these procedures. These patients are all doing well. Complete tumor necrosis was demonstrated in 5 of these 10 patients by pathohistological studies on resected specimens from 1 to 11 months after surgery. These tumors were solitary, small (less than 4 cm in diameter), encapsulated, and located deeply inside the liver, being supplied by a single artery. In the other 5 patients, tumor cells in the main tumor and/or in daughter nodules were viable. We conclude that TAE combined with TAI was justified for treatment of hepatic malignancies in selected cases .
No takes yet. Share an insight, caveat, or question.
Okamura et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: